The Department of Psychiatry is blazing new trails in critical research that connect patient biomarkers and clinical indicators with individual behavioral assessments to advance the prevention, treatment, and cure of mental illnesses across the board. In doing so, we investigate genetic factors, conduct brain imaging studies, scrutinize environmental factors, and pursue all avenues to understand what underlies the physiological storm that leads to psychiatric disease. We move swiftly to translate definitive research findings into trainee education and patient care.
We carry out clinical and translational research projects in conjunction with Mount Sinai Health System’s expertise and resources.
Our Department of Psychiatry's range of divisions, centers, and programs allows us to investigate specific, specialized arms of psychiatry, including the latest in genomic and epigenomic applications. We also train the physicians and scientists of tomorrow, and work directly with patients to deliver the most recent advances in treatment.
Through our laboratories, we conduct a wide variety of leading-edge research, in order to advance the treatment options available to patients.
Our clinical trials in psychiatry offer another opportunity for both patient and clinician to help make tremendous progress in our field.
The Friedman Brain Institute works tirelessly to progress our understanding of the human brain, its physiological complexities and their relationship to behavior, health, and disease.
In direct connection with these areas, we offer a range of residencies and clinical and research fellowships with some of the most diverse and comprehensive training available in the field of psychiatry today.